Future perspectives of anemia management in chronic kidney disease using hypoxia-inducible factor-prolyl hydroxylase inhibitors
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference96 articles.
1. Desidustat in anemia due to non-dialysis-dependent chronic kidney disease: A phase 3 study (DREAM-ND);Agrawal;American Journal of Nephrology,2022
2. Phase 3 study of roxadustat to treat anemia in non-dialysis-dependent CKD;Akizawa;Kidney International,2021
3. A placebo-controlled, randomized trial of enarodustat in patients with chronic kidney disease followed by long-term trial;Akizawa;American Journal of Nephrology,2019
4. A phase 3 study of enarodustat in anemic patients with CKD not requiring dialysis: The SYMPHONY ND study;Akizawa;Kidney International Reports,2021
5. A phase 3 study of enarodustat (JTZ-951) in Japanese hemodialysis patients for treatment of anemia in chronic kidney disease: SYMPHONY HD study;Akizawa;Kidney Diseases,2021
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interplay between hypoxia inducible Factor-1 and mitochondria in cardiac diseases;Free Radical Biology and Medicine;2024-08
2. A study of the visualization of artificial intelligence applications in chronic kidney disease in the literature over the last 20 years;2024-07-11
3. Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus;International Urology and Nephrology;2024-06-27
4. Evaluating the safety and efficacy of vadadustat for the treatment of anemia associated with chronic kidney disease;Expert Opinion on Pharmacotherapy;2024-06-12
5. PDE6G inhibits the expression of CD71 in erythroid progenitor cells through the PDE6G/BHLHE40/miR144-3p/CD71 pathway, leading to red cell production obstacles and ultimately causing anemia in myelofibrosis;2024-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3